var data={"title":"Acute hemorrhagic erosive gastropathy and reactive gastropathy","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Acute hemorrhagic erosive gastropathy and reactive gastropathy</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/contributors\" class=\"contributor contributor_credentials\">Pamela J Jensen, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/contributors\" class=\"contributor contributor_credentials\">Mark Feldman, MD, MACP, AGAF, FACG</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/contributors\" class=\"contributor contributor_credentials\">J Thomas Lamont, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/contributors\" class=\"contributor contributor_credentials\">Shilpa Grover, MD, MPH, AGAF</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 09, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Injury to the gastric mucosa leads to epithelial cell damage and regeneration. The term gastritis is used to denote inflammation associated with gastric mucosal injury. Epithelial cell damage and reactive regeneration without associated inflammation is properly referred to as &quot;gastropathy&quot; [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/1,2\" class=\"abstract_t\">1,2</a>]. (See <a href=\"topic.htm?path=classification-and-diagnosis-of-gastritis-and-gastropathy\" class=\"medical medical_review\">&quot;Classification and diagnosis of gastritis and gastropathy&quot;</a>.)</p><p>The causes, natural history, and therapeutic implications of gastropathy differ from gastritis:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Reactive gastropathy is usually caused by gastric irritants (medications, ethanol, bile reflux), or by mucosal ischemia or vascular congestion. Gastritis is usually due to an infectious agent (such as <em>Helicobacter pylori</em>) or an autoimmune disorder. A practical etiology-based framework for the classification of gastropathy and gastritis is presented (<a href=\"image.htm?imageKey=GAST%2F91372\" class=\"graphic graphic_table graphicRef91372 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/1\" class=\"abstract_t\">1</a>].</p><p/><p>Most classification systems distinguish acute, short-term gastropathy from chronic, long-term disease. The terms acute and chronic are also used in patients with gastritis to describe the type of inflammatory cell infiltrate. Acute (or &quot;active&quot;) gastritis is associated with neutrophilic infiltration, while chronic gastritis is characterized by mononuclear cells, chiefly lymphocytes, plasma cells, and macrophages. An etiology-based classification of gastropathy and gastritis is outlined in the table (<a href=\"image.htm?imageKey=GAST%2F91372\" class=\"graphic graphic_table graphicRef91372 \">table 1</a>).</p><p>This topic review will discuss acute hemorrhagic and erosive gastropathy and reactive gastropathy. The classification and diagnosis of gastropathy and gastritis, and the causes of acute and chronic gastritis are presented separately. (See <a href=\"topic.htm?path=classification-and-diagnosis-of-gastritis-and-gastropathy\" class=\"medical medical_review\">&quot;Classification and diagnosis of gastritis and gastropathy&quot;</a> and <a href=\"topic.htm?path=acute-and-chronic-gastritis-due-to-helicobacter-pylori\" class=\"medical medical_review\">&quot;Acute and chronic gastritis due to Helicobacter pylori&quot;</a> and <a href=\"topic.htm?path=metaplastic-chronic-atrophic-gastritis\" class=\"medical medical_review\">&quot;Metaplastic (chronic) atrophic gastritis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">ACUTE HEMORRHAGIC EROSIVE GASTROPATHY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The hallmark of acute hemorrhagic erosive gastropathy is the development of hemorrhagic and erosive lesions shortly after exposure of the gastric mucosa to various injurious substances or after a substantial reduction in mucosal blood flow. The gastropathy is caused by damage to the surface epithelium, which may be due to a direct action of injurious agents (such as nonsteroidal anti-inflammatory drugs [NSAIDs], alcohol, or bile acids) or to mucosal ischemia with tissue hypoxia (such as in trauma, burns [Curling's ulcers] or sepsis) or to a combination of factors such as with antineoplastic chemotherapy. Gastric and duodenal ulceroinflammatory lesions occurring during severe damage to the central nervous system (Cushing's ulcers) are often considered in this group, although some authorities consider them to be clinically and pathogenetically distinct [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/3,4\" class=\"abstract_t\">3,4</a>]. (See <a href=\"topic.htm?path=stress-ulcer-prophylaxis-in-the-intensive-care-unit\" class=\"medical medical_review\">&quot;Stress ulcer prophylaxis in the intensive care unit&quot;</a>.)</p><p>As a result of the acute mucosal injury, the normal protective barrier (which includes secreted mucins, bicarbonate, and the epithelium itself) is disrupted. This permits acid and other luminal substances (eg, pepsin and bile acids) to penetrate into the lamina propria, where they cause additional injury to the vasculature, stimulate nerves, and cause the release of histamine and other inflammatory mediators [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/5,6\" class=\"abstract_t\">5,6</a>]. The mucosal injury increases significantly during the reperfusion that follows ischemia due to the production of toxic oxygen-free radicals by infiltrating neutrophils [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/7\" class=\"abstract_t\">7</a>].</p><p>An additional pathogenetic factor in NSAID-induced acute hemorrhagic and erosive gastropathy is the inhibition of prostaglandin production. Prostaglandins protect against acute mucosal injury due to injurious substances by several mechanisms, including stimulation of mucus and bicarbonate secretion and increased vascular permeability, resulting in perivascular edema that dilutes and delays toxic agents reaching subepithelial capillaries [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/8,9\" class=\"abstract_t\">8,9</a>]. (See <a href=\"topic.htm?path=nsaids-including-aspirin-pathogenesis-of-gastroduodenal-toxicity\" class=\"medical medical_review\">&quot;NSAIDs (including aspirin): Pathogenesis of gastroduodenal toxicity&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Clinical features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute gastropathy often presents with abdominal <span class=\"nowrap\">discomfort/pain,</span> heartburn, nausea, vomiting, and hematemesis. Bleeding may be delayed until three to seven days following the stressful event and can range from occult blood to massive hemorrhage.</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Pathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute hemorrhagic erosive gastropathy appears as multiple petechial hemorrhages and small red or black erosions on endoscopy [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/10,11\" class=\"abstract_t\">10,11</a>]. Stress-related lesions (including Curling's ulcers) usually appear in the fundus near the gastroesophageal junction and spread distally, but remain confined to the fundus and body [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/11\" class=\"abstract_t\">11</a>]. In contrast, gastropathy due to NSAIDs and alcohol ingestion involves the entire stomach from the start, although it may be most evident in the antrum [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/11\" class=\"abstract_t\">11</a>]. The erosions in NSAID and alcohol-induced hemorrhagic gastropathy are usually smaller and more rapidly reversible than those seen in hypovolemic (ischemic) gastropathy [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/11\" class=\"abstract_t\">11</a>].</p><p>Erosions may have only subtle histological features because mucosal restitution and repair are rapid. In many cases, an attenuated regenerative appearing epithelium provides the only evidence for their occurrence [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/4\" class=\"abstract_t\">4</a>]. Inflammation is usually slight (consisting of no more than a few neutrophils) or absent. Mucosal changes range from hyperemia to massive mucosal necrosis.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Ulceration</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute hemorrhagic erosive gastropathy may be associated with the development of gastric and duodenal ulcers. Acute ulceration is most likely to occur in relation to shock-induced hemodynamic instability (ie, the stress ulcer syndrome). Ulcers are usually multiple, shallow, 0.5 to 2.0 cm in diameter, and almost exclusively located in the corpus and fundus [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/3,4,11,12\" class=\"abstract_t\">3,4,11,12</a>]. (See <a href=\"topic.htm?path=causes-of-upper-gastrointestinal-bleeding-in-adults\" class=\"medical medical_review\">&quot;Causes of upper gastrointestinal bleeding in adults&quot;</a>.)</p><p>The pathologic appearance of the ulcers depends upon their age. Ulcers initially appear necrotic, while older ulcers often demonstrate inflammation, granulation tissue, and epithelial cell regeneration. Ulcers of various ages can usually be found in the same patient [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/12\" class=\"abstract_t\">12</a>].</p><p>Gastric (or duodenal) ulcers developing in the setting of acute hemorrhagic gastropathy may be associated with significant bleeding if they extend below the muscularis mucosae into deeper layers where large vessels are located [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/3,4,12\" class=\"abstract_t\">3,4,12</a>]. Bleeding is more common from gastric than duodenal ulcers.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Common causative agents</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Alcohol &ndash; Alcohol exerts a direct toxic effect on gastric epithelium. Additionally, alcohol impairs gastric motility, leading to delayed gastric emptying and consequent prolonged mucosal contact time, further exacerbating the toxic injury [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/13\" class=\"abstract_t\">13</a>]. Injury is dose-dependent and usually requires a gastric alcohol concentration of &gt;10 percent [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/14\" class=\"abstract_t\">14</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>NSAIDs &ndash; Damage can include acute hemorrhagic gastropathy, erosions, reactive gastropathy, ulcers, and perforation. PPIs have been used to mitigate symptoms; however, there have been reports suggesting that PPIs can exacerbate NSAID-induced enteropathy, particularly within the small intestine [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/15\" class=\"abstract_t\">15</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cancer chemotherapy &ndash; Damage to gastric mucosa is multifactorial and includes direct mucosal injury, vomiting-induced injury, and cancer-mediated or chemotherapy-induced immunosuppression (with opportunistic gastric infections). Hepatic arterial infusion chemotherapy can produce alarming regenerative cellular atypia easily confused with carcinoma [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/16\" class=\"abstract_t\">16</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Iron pills &ndash; The consumption of large amounts of oral iron may lead to gastric mucosal necrosis, erosions, and ulcers. Brown pigment may be seen overlying the damaged epithelium [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/17\" class=\"abstract_t\">17</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cocaine &ndash; Injury is caused by intense vasoconstriction with subsequent ischemia due to activation of alpha-adrenergic receptors in the mesentery [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/18\" class=\"abstract_t\">18</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral <a href=\"topic.htm?path=sodium-phosphate-drug-information\" class=\"drug drug_general\">sodium phosphate</a> preparations &ndash; Oral sodium phosphate preparations, used for colonoscopy bowel preparation, are associated with acute hemorrhagic gastropathy [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/19\" class=\"abstract_t\">19</a>]. (See <a href=\"topic.htm?path=bowel-preparation-before-colonoscopy-in-adults#H2551245625\" class=\"medical medical_review\">&quot;Bowel preparation before colonoscopy in adults&quot;, section on 'Sodium phosphate preparations'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Treatment and prevention</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Treatment of acute hemorrhagic erosive gastropathy depends upon the cause. The underlying cause should be removed or treated whenever possible. Antisecretory therapy is also often used to limit concomitant damage from luminal acid exposure.</p><p>A variety of measures may also be effective for prevention of acute hemorrhagic gastropathy in high-risk patients. Examples include antisecretory agents (proton pump inhibitors or H2 receptor antagonists) to prevent stress ulceration in the intensive care unit (see <a href=\"topic.htm?path=stress-ulcer-prophylaxis-in-the-intensive-care-unit\" class=\"medical medical_review\">&quot;Stress ulcer prophylaxis in the intensive care unit&quot;</a>) and for those undergoing chemotherapy.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">REACTIVE GASTROPATHY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Long-term exposure to substances capable of injuring the gastric mucosa can lead to reactive gastropathy. This disorder is characterized by a paucity of inflammation, variable degrees of foveolar hyperplasia, mucosal edema, proliferation of smooth muscle fibers in the lamina propria, and vascular dilation and congestion. These changes were first recognized in severe bile reflux gastropathy [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/20\" class=\"abstract_t\">20</a>], and have subsequently been observed in biopsy specimens from patients with chronic nonsteroidal anti-inflammatory drug (NSAID)-related mucosal injury [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/21\" class=\"abstract_t\">21</a>]. <a href=\"topic.htm?path=alendronate-drug-information\" class=\"drug drug_general\">Alendronate</a>, which can cause acute gastropathy [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/22\" class=\"abstract_t\">22</a>], can also cause reactive gastropathy.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Clinical features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of reactive gastropathy is usually established on biopsy specimens from patients undergoing upper endoscopy for evaluation of upper abdominal symptoms. Although there are no endoscopic findings that are diagnostic, mucosal changes are usually confined to the antrum or gastroenterostomy sites.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Histopathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A key histologic feature in reactive gastropathy is the paucity of inflammation, which is in sharp contrast to <em>H. pylori</em> gastritis. In addition, a constellation of findings may be evident, including foveolar hyperplasia, edema, increased smooth muscle fibers in the lamina propria, and vascular dilatation and congestion [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/20\" class=\"abstract_t\">20</a>]. (See <a href=\"topic.htm?path=acute-and-chronic-gastritis-due-to-helicobacter-pylori\" class=\"medical medical_review\">&quot;Acute and chronic gastritis due to Helicobacter pylori&quot;</a>.)</p><p>Foveolar hyperplasia is characterized by lengthening of the foveolae, with individual cells having reduced height and depletion of intracellular mucin. The glands may take on a tortuous, corkscrew appearance in severe cases, as is commonly seen in biopsy specimens taken near gastroenterostomy stomas (in which gastropathy is usually due to bile reflux). Foveolar hyperplasia is part of a spectrum of hyperplastic changes that are found near gastroenterostomies; others include discrete polypoid lesions (ie, polypoid hypertrophic gastritis or gastritis cystica polyposa) [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/23\" class=\"abstract_t\">23</a>]. Foveolar hyperplasia can regress after bile is diverted from the gastroenterostomies [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/24\" class=\"abstract_t\">24</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Chronic NSAID-associated reactive gastropathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenetic connection between the acute hemorrhagic erosive gastropathy and the chronic reactive gastropathy associated with NSAIDs is not well understood. Continued, regular administration of NSAIDs in humans and experimental animals can lead to a reduction in visible hemorrhages and erosions as a result of mucosal adaptation [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/25-29\" class=\"abstract_t\">25-29</a>]. However, many patients who take these drugs for prolonged periods continue to have ulceroinflammatory lesions with mucosal hemorrhages and erosions or, in approximately 15 percent of patients, gastric or duodenal ulceration [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/30,31\" class=\"abstract_t\">30,31</a>]. This outcome has been referred to as &quot;failed adaptation&quot; [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/32\" class=\"abstract_t\">32</a>]. <em>H. pylori</em> infection is known to exacerbate severe gastric mucosal injury in chronic NSAID users, possibly due to impairment of this adaptation process [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/33\" class=\"abstract_t\">33</a>] (see <a href=\"topic.htm?path=nsaids-including-aspirin-pathogenesis-of-gastroduodenal-toxicity\" class=\"medical medical_review\">&quot;NSAIDs (including aspirin): Pathogenesis of gastroduodenal toxicity&quot;</a>). The chronic poorly healing erosions and ulcers that often accompany NSAID-induced reactive gastropathy are usually associated with suppressed epithelial cell regeneration, which can be detected in biopsies obtained from the edge of ulcers [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/34,35\" class=\"abstract_t\">34,35</a>]. The presence of scarring in the muscularis mucosae and submucosa in gastric resection specimens from NSAID users is also consistent with repeated episodes of erosion, ulceration, and repair.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Bile reflux gastropathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bile reflux gastropathy typically results from the entry of bile into the stomach because of an operative stoma, an incompetent pyloric sphincter, or abnormal duodenal motility [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/36\" class=\"abstract_t\">36</a>]. The degree of injury reflects the amount of exposure to bile salts. Patients who have a gastroenterostomy, for example, demonstrate the greatest degree of foveolar hyperplasia near the stoma, with decreasing changes proximally [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/20,23,37\" class=\"abstract_t\">20,23,37</a>]. Bile salt concentration in gastric juice correlates with the severity of foveolar hyperplasia in these patients.</p><p>The effect of bile salts on the gastric mucosa is comparable to that seen after chronic NSAID use [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/36\" class=\"abstract_t\">36</a>]. Bile salts also appear to be a risk factor for the development of antral metaplastic gastritis [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/38\" class=\"abstract_t\">38</a>]. Animal studies have demonstrated that bile salts and lysolecithin (derived from the metabolism of lecithin) cause gastric mucosal injury [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/39,40\" class=\"abstract_t\">39,40</a>]. Their degree of toxicity is influenced by a number of variables including the type of bile salt, the presence or absence of deconjugation of bile salts by bacteria in the intestine or stomach, the gastric pH, and the presence of pancreatic enzymes. Pancreatic enzymes in particular enhance injury from bile salts, in part because they can catalyze formation of lysolecithin from lecithin.</p><p>Lysolecithin and bile salts break down the gastric mucosal barrier [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/41\" class=\"abstract_t\">41</a>], leading to back-diffusion of hydrogen ions and mucosal injury [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/39,40\" class=\"abstract_t\">39,40</a>]. Concomitant infection by <em>H. pylori</em> can cause increased inflammation [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/42,43\" class=\"abstract_t\">42,43</a>]. Cytoprotection from bile-induced injury by prostaglandins has been demonstrated in animal studies [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/44\" class=\"abstract_t\">44</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h3\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Symptoms in patients with chronic bile acid reflux gastropathy are variable, ranging from histologic changes only without symptoms to abdominal pain, bilious vomiting and weight loss [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/45\" class=\"abstract_t\">45</a>]. The diagnosis of bile reflux gastropathy is easiest in patients who have surgically altered anatomy predisposing to bile reflux. The demonstration of reactive gastropathy in the absence of other causes is usually sufficient. In contrast, gastropathy in patients with non-operated stomachs should not be attributed to exposure to bile without evidence of duodenogastric reflux. Duodenogastric reflux can be demonstrated by visualization during endoscopy, bile salt analysis in gastric juice, or radionuclide scanning [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/36,43,46,47\" class=\"abstract_t\">36,43,46,47</a>].</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Definitive treatment of symptomatic chronic bile acid reflux gastropathy is surgery to divert bile from refluxing into the stomach (usually a Roux-en-Y revision), which has been associated with improvement in symptoms in 50 to 90 percent of patients in several reports [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/45,48-50\" class=\"abstract_t\">45,48-50</a>]. Improvement is less likely in patients with delayed gastric emptying [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/48\" class=\"abstract_t\">48</a>].</p><p>A number of medical treatments have been evaluated in small clinical trials with variable success:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=ursodeoxycholic-acid-ursodiol-drug-information\" class=\"drug drug_general\">Ursodeoxycholic acid</a> (ursodiol) significantly decreased pain and almost abolished nausea and vomiting, but did not improve histology in a small placebo-controlled crossover trial involving 12 patients [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/51\" class=\"abstract_t\">51</a>]. The rationale for its use was based upon the hypothesis that changing the composition of bile acids could have a favorable effect on gastric mucosa and symptoms. A subsequent non-randomized trial suggested that ursodiol is superior to a proton pump inhibitor in these patients [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/52\" class=\"abstract_t\">52</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=sucralfate-drug-information\" class=\"drug drug_general\">Sucralfate</a> improved histologic features but not symptoms in a controlled trial involving 23 patients [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/53\" class=\"abstract_t\">53</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prostaglandin E2 was ineffective in improving endoscopic features or symptoms in a double-blind crossover trial [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/54\" class=\"abstract_t\">54</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=cholestyramine-resin-drug-information\" class=\"drug drug_general\">Cholestyramine</a> combined with alginates (to improve contact time in the gastric remnant) was ineffective on symptoms or histology in a placebo controlled trial that included 32 patients [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/55\" class=\"abstract_t\">55</a>].</p><p/><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Alcohol and other possible causes of reactivegastropathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>It is often difficult to establish with certainty that a particular agent, such as alcohol (ethanol) has caused gastropathy [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/25,56\" class=\"abstract_t\">25,56</a>]. Exposure of the gastric mucosa to alcohol is associated with acute hemorrhagic and erosive gastropathy in experimental animals and humans, and chronic alcoholism correlates with presence of hemorrhagic and erosive lesions, [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/57-59\" class=\"abstract_t\">57-59</a>]. However, the available evidence does <strong>not</strong> convincingly support the conclusion that alcoholic beverages cause reactive gastropathy [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/13,60-62\" class=\"abstract_t\">13,60-62</a>]. Investigations directed at correlating alcohol consumption and chronic gastropathy are difficult to conduct because of numerous confounding variables, including the presence of other potential causes of gastric injury such as smoking, NSAID use, and <em>H. pylori</em> infection. The types of alcoholic beverages consumed also may be important because of variations in alcohol concentration as well as important differences in content between distilled and fermented alcohols [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/13\" class=\"abstract_t\">13</a>].</p><p>Although some investigators have described a correlation between alcohol consumption and chronic gastritis, most such studies antedated the awareness of <em>H. pylori</em> gastritis [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/63\" class=\"abstract_t\">63</a>]. The text and photomicrographs in these articles strongly suggest that the chronic gastritis seen was due to <em>H. pylori</em>. Supporting this hypothesis is one investigation in which chronic gastritis was not found in the absence of <em>H. pylori</em> infection in a small group of alcoholics [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/62\" class=\"abstract_t\">62</a>]. (See <a href=\"topic.htm?path=acute-and-chronic-gastritis-due-to-helicobacter-pylori\" class=\"medical medical_review\">&quot;Acute and chronic gastritis due to Helicobacter pylori&quot;</a>.)</p><p>Other oral agents known to be injurious to gastric mucosa and likely causing reactive gastropathy with chronic use include potassium [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/64\" class=\"abstract_t\">64</a>] and iron supplements [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/65-67\" class=\"abstract_t\">65-67</a>]. Although smoking is a risk factor for peptic ulcer disease, there is little or no evidence that smoking causes reactive gastropathy [<a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/21,25\" class=\"abstract_t\">21,25</a>]. The possible role of chronic hyperacidity in chemical gastropathy remains to be clarified.</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Epithelial cell damage and regeneration without associated inflammation is defined as &quot;gastropathy.&quot; (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H185154678\"><span class=\"h2\">Acute hemorrhagic erosive gastropathy</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The hallmark of acute hemorrhagic erosive gastropathy is the development of hemorrhagic and erosive lesions shortly after exposure of the gastric mucosa to various injurious substances or a substantial reduction in mucosal blood flow. (See <a href=\"#H2\" class=\"local\">'Acute hemorrhagic erosive gastropathy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute hemorrhagic erosive gastropathy is usually caused by irritants such as drugs (eg, nonsteroidal anti-inflammatory drugs [NSAIDs] and alcohol), bile reflux, hypovolemia, and chronic congestion. (See <a href=\"#H6\" class=\"local\">'Common causative agents'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute hemorrhagic and erosive gastropathy appears as multiple petechial hemorrhages and small red or black erosions on endoscopy. (See <a href=\"#H4\" class=\"local\">'Pathology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute hemorrhagic erosive gastropathy often presents as abdominal discomfort, pain, heartburn, nausea, vomiting, and hematemesis. Bleeding may be seen three to seven days following the stressful event and can range from occult blood to massive hemorrhage. (See <a href=\"#H9\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The offending agent should be eliminated in patients with acute hemorrhagic erosive gastropathy. Preventive measures should be considered in patients at risk while patients with overt gastrointestinal bleeding should be treated with a proton pump inhibitor. (See <a href=\"#H7\" class=\"local\">'Treatment and prevention'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H13127018\"><span class=\"h2\">Reactive gastropathy</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Long-term exposure to substances capable of injuring the gastric mucosa can lead to reactive gastropathy. Causes of chronic chemical gastropathy include NSAIDs, bile reflux, and possibly alcohol. (See <a href=\"#H11\" class=\"local\">'Chronic NSAID-associated reactive gastropathy'</a> above and <a href=\"#H12\" class=\"local\">'Bile reflux gastropathy'</a> above and <a href=\"#H15\" class=\"local\">'Alcohol and other possible causes of reactivegastropathy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of reactive gastropathy is usually established on biopsy specimens from patients undergoing upper endoscopy for evaluation of upper abdominal symptoms. (See <a href=\"#H13\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Reactive gastropathy is characterized by a paucity of inflammation, variable degrees of foveolar hyperplasia, edema, proliferation of smooth muscle fibers in the lamina propria, and vascular dilatation and congestion. (See <a href=\"#H10\" class=\"local\">'Histopathology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The presumed offending agent should be eliminated in patients with reactive gastropathy, if possible. </p><p/><p class=\"bulletIndent1\">In patients with bile acid reflux, surgery diverting bile from refluxing into the stomach is the definitive treatment. Medical treatments for bile acid reflux have been evaluated in small clinical trials with variable success. (See <a href=\"#H14\" class=\"local\">'Treatment'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/1\" class=\"nounderline abstract_t\">Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/2\" class=\"nounderline abstract_t\">Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology 1995; 108:917.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/3\" class=\"nounderline abstract_t\">Marrone GC, Silen W. Pathogenesis, diagnosis and treatment of acute gastric mucosal lesions. Clin Gastroenterol 1984; 13:635.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/4\" class=\"nounderline abstract_t\">Silen W. The clinical problem of stress ulcers. Clin Invest Med 1987; 10:270.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/5\" class=\"nounderline abstract_t\">Davenport HW. Salicylate damage to the gastric mucosal barrier. N Engl J Med 1967; 276:1307.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/6\" class=\"nounderline abstract_t\">Oates PJ, Hakkinen JP. Studies on the mechanism of ethanol-induced gastric damage in rats. Gastroenterology 1988; 94:10.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/7\" class=\"nounderline abstract_t\">Hernandez LA, Grisham MB, Twohig B, et al. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 1987; 253:H699.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/8\" class=\"nounderline abstract_t\">Robert A, Nezamis JE, Lancaster C, Hanchar AJ. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979; 77:433.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/9\" class=\"nounderline abstract_t\">Szabo S. &quot;Gastric cytoprotection&quot; is still relevant. J Gastroenterol Hepatol 2014; 29 Suppl 4:124.</a></li><li class=\"breakAll\">Sloan JM. Acute haemorrhage gastritis and acute infective gastritis, gastritis caused by physical agents and corrosives, uraemic gastritis. In: Gastrointestinal and Oesophageal Pathology, Whitehead R (Ed), Churchill Livingstone, Edinburgh 1989. p.385.</li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/11\" class=\"nounderline abstract_t\">Sugawa C, Lucas CE, Rosenberg BF, et al. Differential topography of acute erosive gastritis due to trauma or sepsis, ethanol and aspirin. Gastrointest Endosc 1973; 19:127.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/12\" class=\"nounderline abstract_t\">Lev R, Molot MD, McNamara J, Stremple JF. &quot;Stress&quot; ulcers following war wounds in Vietnam. A morphologic and histochemical study. Lab Invest 1971; 25:491.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/13\" class=\"nounderline abstract_t\">Franke A, Teyssen S, Singer MV. Alcohol-related diseases of the esophagus and stomach. Dig Dis 2005; 23:204.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/14\" class=\"nounderline abstract_t\">Kvietys PR, Twohig B, Danzell J, Specian RD. Ethanol-induced injury to the rat gastric mucosa. Role of neutrophils and xanthine oxidase-derived radicals. Gastroenterology 1990; 98:909.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/15\" class=\"nounderline abstract_t\">Minalyan A, Gabrielyan L, Scott D, et al. The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors. Curr Gastroenterol Rep 2017; 19:42.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/16\" class=\"nounderline abstract_t\">Petras RE, Hart WR, Bukowski RM. Gastric epithelial atypia associated with hepatic arterial infusion chemotherapy. Its distinction from early gastric carcinoma. Cancer 1985; 56:745.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/17\" class=\"nounderline abstract_t\">Haig A, Driman DK. Iron-induced mucosal injury to the upper gastrointestinal tract. Histopathology 2006; 48:808.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/18\" class=\"nounderline abstract_t\">Gourgoutis G, Das G. Gastrointestinal manifestations of cocaine addiction. Int J Clin Pharmacol Ther 1994; 32:136.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/19\" class=\"nounderline abstract_t\">Nam SY, Choi IJ, Park KW, et al. Risk of hemorrhagic gastropathy associated with colonoscopy bowel preparation using oral sodium phosphate solution. Endoscopy 2010; 42:109.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/20\" class=\"nounderline abstract_t\">Dixon MF, O'Connor HJ, Axon AT, et al. Reflux gastritis: distinct histopathological entity? J Clin Pathol 1986; 39:524.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/21\" class=\"nounderline abstract_t\">Sobala GM, King RF, Axon AT, Dixon MF. Reflux gastritis in the intact stomach. J Clin Pathol 1990; 43:303.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/22\" class=\"nounderline abstract_t\">Graham DY, Malaty HM, Goodgame R. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin. Am J Gastroenterol 1997; 92:1322.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/23\" class=\"nounderline abstract_t\">Koga S, Watanabe H, Enjoji M. Stomal polypoid hypertrophic gastritis: a polypoid gastric lesion at gastroenterostomy site. Cancer 1979; 43:647.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/24\" class=\"nounderline abstract_t\">Bechi P, Amorosi A, Mazzanti R, et al. Short-term effects of bile diversion on postgastrectomy gastric histology. Dig Dis Sci 1988; 33:1288.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/25\" class=\"nounderline abstract_t\">Domschke S, Domschke W. Gastroduodenal damage due to drugs, alcohol and smoking. Clin Gastroenterol 1984; 13:405.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/26\" class=\"nounderline abstract_t\">Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med 1986; 104:390.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/27\" class=\"nounderline abstract_t\">Roth SH, Bennett RE. Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response. Arch Intern Med 1987; 147:2093.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/28\" class=\"nounderline abstract_t\">Shorrock CJ, Rees WD. Mucosal adaptation to indomethacin induced gastric damage in man--studies on morphology, blood flow, and prostaglandin E2 metabolism. Gut 1992; 33:164.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/29\" class=\"nounderline abstract_t\">Konturek SJ, Brzozowski T, Majka J, et al. Adaptation of the gastric mucosa to stress. Role of prostaglandin and epidermal growth factor. Scand J Gastroenterol Suppl 1992; 193:39.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/30\" class=\"nounderline abstract_t\">Silvoso GR, Ivey KJ, Butt JH, et al. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979; 91:517.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/31\" class=\"nounderline abstract_t\">Larkai EN, Smith JL, Lidsky MD, Graham DY. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 1987; 82:1153.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/32\" class=\"nounderline abstract_t\">Olivero JJ, Graham DY. Gastric adaptation to nonsteroidal anti-inflammatory drugs in man. Scand J Gastroenterol Suppl 1992; 193:53.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/33\" class=\"nounderline abstract_t\">Kono Y, Okada H, Takenaka R, et al. Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study. Gut Liver 2016; 10:69.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/34\" class=\"nounderline abstract_t\">Levi S, Goodlad RA, Lee CY, et al. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990; 336:840.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/35\" class=\"nounderline abstract_t\">Myszor M, Hodgson HJ. Non-steroidal anti-inflammatory drugs and gastric DNA synthesis. Scand J Gastroenterol 1990; 25:197.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/36\" class=\"nounderline abstract_t\">Niemel&auml; S. Duodenogastric reflux in patients with upper abdominal complaints or gastric ulcer with particular reference to reflux-associated gastritis. Scand J Gastroenterol Suppl 1985; 115:1.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/37\" class=\"nounderline abstract_t\">Weinstein WM, Buch KL, Elashoff J, et al. The histology of the stomach in symptomatic patients after gastric surgery: a model to assess selective patterns of gastric mucosal injury. Scand J Gastroenterol Suppl 1985; 109:77.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/38\" class=\"nounderline abstract_t\">Nakamura M, Haruma K, Kamada T, et al. Duodenogastric reflux is associated with antral metaplastic gastritis. Gastrointest Endosc 2001; 53:53.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/39\" class=\"nounderline abstract_t\">Orchard R, Reynolds K, Fox B, et al. Effect of lysolecithin on gastric mucosal structure and potential difference. Gut 1977; 18:457.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/40\" class=\"nounderline abstract_t\">Eastwood GL. Effect of pH on bile salt injury to mouse gastric mucosa. A light- and electron-microscopic study. Gastroenterology 1975; 68:1456.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/41\" class=\"nounderline abstract_t\">Davenport HW. Destruction of the gastric mucosal barrier by detergents and urea. Gastroenterology 1968; 54:175.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/42\" class=\"nounderline abstract_t\">Loffeld RJ, Loffeld BC, Arends JW, et al. Retrospective study of Campylobacter-like organisms in patients undergoing partial gastrectomy. J Clin Pathol 1988; 41:1313.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/43\" class=\"nounderline abstract_t\">Karttunen T, Niemel&auml; S. Campylobacter pylori and duodenogastric reflux in peptic ulcer disease and gastritis. Lancet 1988; 1:118.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/44\" class=\"nounderline abstract_t\">Dempsey DT, Mercer DW, Deb B, et al. Adaptive cytoprotection of gastric surface epithelial cells against injury by physiologic concentrations of bile acid. Surgery 1990; 108:348.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/45\" class=\"nounderline abstract_t\">Bondurant FJ, Maull KI, Nelson HS Jr, Silver SH. Bile reflux gastritis. South Med J 1987; 80:161.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/46\" class=\"nounderline abstract_t\">Stein HJ, Smyrk TC, DeMeester TR, et al. Clinical value of endoscopy and histology in the diagnosis of duodenogastric reflux disease. Surgery 1992; 112:796.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/47\" class=\"nounderline abstract_t\">Niemel&auml; S, Karttunen T, Heikkil&auml; J, Lehtola J. Characteristics of reflux gastritis. Scand J Gastroenterol 1987; 22:349.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/48\" class=\"nounderline abstract_t\">Davidson ED, Hersh T. The surgical treatment of bile reflux gastritis: a study of 59 patients. Ann Surg 1980; 192:175.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/49\" class=\"nounderline abstract_t\">Capussotti L, Marucci MM, Arico S, et al. Long-term results of surgical treatment for alkaline reflux gastritis in gastrectomized patients. Am J Gastroenterol 1984; 79:924.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/50\" class=\"nounderline abstract_t\">Tass&eacute; D, Ghosn PO, Gagnon M, et al. Alkaline reflux gastritis: Roux-en-Y diversion is effective. Can J Surg 1982; 25:337.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/51\" class=\"nounderline abstract_t\">Stefaniwsky AB, Tint GS, Speck J, et al. Ursodeoxycholic acid treatment of bile reflux gastritis. Gastroenterology 1985; 89:1000.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/52\" class=\"nounderline abstract_t\">Kumar N, Thompson CC. Remnant gastropathy due to bile reflux after Roux-en-Y gastric bypass: a unique cause of abdominal pain and successful treatment with ursodiol. Surg Endosc 2017; 31:5399.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/53\" class=\"nounderline abstract_t\">Buch KL, Weinstein WM, Hill TA, et al. Sucralfate therapy in patients with symptoms of alkaline reflux gastritis. A randomized, double-blind study. Am J Med 1985; 79:49.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/54\" class=\"nounderline abstract_t\">Nicolai JJ, van de Stadt J, Tytgat GN. Double-blind crossover trial of prostaglandin E2 in postgastrectomy reflux gastritis. Dig Dis Sci 1986; 31:1281.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/55\" class=\"nounderline abstract_t\">Nicolai JJ, Speelman P, Tytgat GN, van der Stadt J. Comparison of the combination of cholestyramine/alginates with placebo in the treatment of postgastrectomy biliary reflux gastritis. Eur J Clin Pharmacol 1981; 21:189.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/56\" class=\"nounderline abstract_t\">Kurata JH, Elashoff JD, Grossman MI. Inadequacy of the literature on the relationship between drugs, ulcers, and gastrointestinal bleeding. Gastroenterology 1982; 82:373.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/57\" class=\"nounderline abstract_t\">Laine L, Weinstein WM. Histology of alcoholic hemorrhagic &quot;gastritis&quot;: a prospective evaluation. Gastroenterology 1988; 94:1254.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/58\" class=\"nounderline abstract_t\">Segawa K, Nakazawa S, Tsukamoto Y, et al. Endoscopic study of upper gastrointestinal tract in patients with alcohol dependence. Jpn J Med 1987; 26:21.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/59\" class=\"nounderline abstract_t\">Bernersen B, Johnsen R, Straume B, Burhol PG. Erosive prepyloric changes in dyspeptics and non-dyspeptics in a defined population. The S&oslash;rreisa Gastrointestinal Disorder Study. Scand J Gastroenterol 1992; 27:233.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/60\" class=\"nounderline abstract_t\">Cheli R, Giacosa A, Marenco G, et al. Chronic gastritis and alcohol. Z Gastroenterol 1981; 19:459.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/61\" class=\"nounderline abstract_t\">Oddsson E, Binder V, Thorgeirsson T, et al. A prospective comparative study of clinical and pathological characteristics in Icelandic and Danish patients with gastric ulcer, duodenal ulcer, and X-ray negative dyspepsia. II. Histological results. Scand J Gastroenterol 1978; 13:489.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/62\" class=\"nounderline abstract_t\">Uppal R, Lateef SK, Korsten MA, et al. Chronic alcoholic gastritis. Roles of alcohol and Helicobacter pylori. Arch Intern Med 1991; 151:760.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/63\" class=\"nounderline abstract_t\">Parl FF, Lev R, Thomas E, Pitchumoni CS. Histologic and morphometric study of chronic gastritis in alcoholic patients. Hum Pathol 1979; 10:45.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/64\" class=\"nounderline abstract_t\">McMahon FG, Ryan JR, Akdamar K, Ertan A. Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial. Lancet 1982; 2:1059.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/65\" class=\"nounderline abstract_t\">Shafique K, Araujo JL, Veluvolu R, et al. Mitochondrial Iron Accumulation in Parietal and Chief Cells in Iron Pill Gastritis Following Billroth II Gastrectomy: Case Report Including Electron Microscopic Examination. Ann Clin Lab Sci 2017; 47:354.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/66\" class=\"nounderline abstract_t\">Meli&#355; LE, M&#259;rginean CO, Mocanu S, M&#259;rginean MO. A rare case of iron-pill induced gastritis in a female teenager: A case report and a review of the literature. Medicine (Baltimore) 2017; 96:e7550.</a></li><li><a href=\"https://www.uptodate.com/contents/acute-hemorrhagic-erosive-gastropathy-and-reactive-gastropathy/abstract/67\" class=\"nounderline abstract_t\">Sunkara T, Caughey ME, Nigar S, et al. Iron Pill Gastritis: An Under Diagnosed Condition With Potentially Serious Outcomes. Gastroenterology Res 2017; 10:138.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 36 Version 10.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H16\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">ACUTE HEMORRHAGIC EROSIVE GASTROPATHY</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Clinical features</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Pathology</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">- Ulceration</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">- Common causative agents</a></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">Treatment and prevention</a></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">REACTIVE GASTROPATHY</a><ul><li><a href=\"#H9\" id=\"outline-link-H9\">Clinical features</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Histopathology</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Chronic NSAID-associated reactive gastropathy</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Bile reflux gastropathy</a><ul><li><a href=\"#H13\" id=\"outline-link-H13\">- Diagnosis</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">- Treatment</a></li></ul></li><li><a href=\"#H15\" id=\"outline-link-H15\">Alcohol and other possible causes of reactivegastropathy</a></li></ul></li><li><a href=\"#H16\" id=\"outline-link-H16\">SUMMARY AND RECOMMENDATIONS</a><ul><li><a href=\"#H185154678\" id=\"outline-link-H185154678\">Acute hemorrhagic erosive gastropathy</a></li><li><a href=\"#H13127018\" id=\"outline-link-H13127018\">Reactive gastropathy</a></li></ul></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/36|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/91372\" class=\"graphic graphic_table\">- Etiology-based classification of gastropathy and gastritis</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-and-chronic-gastritis-due-to-helicobacter-pylori\" class=\"medical medical_review\">Acute and chronic gastritis due to Helicobacter pylori</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bowel-preparation-before-colonoscopy-in-adults\" class=\"medical medical_review\">Bowel preparation before colonoscopy in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=causes-of-upper-gastrointestinal-bleeding-in-adults\" class=\"medical medical_review\">Causes of upper gastrointestinal bleeding in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=classification-and-diagnosis-of-gastritis-and-gastropathy\" class=\"medical medical_review\">Classification and diagnosis of gastritis and gastropathy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=metaplastic-chronic-atrophic-gastritis\" class=\"medical medical_review\">Metaplastic (chronic) atrophic gastritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nsaids-including-aspirin-pathogenesis-of-gastroduodenal-toxicity\" class=\"medical medical_review\">NSAIDs (including aspirin): Pathogenesis of gastroduodenal toxicity</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=stress-ulcer-prophylaxis-in-the-intensive-care-unit\" class=\"medical medical_review\">Stress ulcer prophylaxis in the intensive care unit</a></li></ul></div></div>","javascript":null}